AA
EVH icon

AlphaCentric Advisors’s Evolent Health EVH Stock Holding History

AlphaCentric Advisors’s Portfolio EVH Stock Details EVH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		$60.8K Buy
+5,404
New +$95K 0.06% 186

Other funds holding EVH

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
EC
Engaged Capital Newport Beach, California $303M AUM 2.09% 1-Year Est. Return
CCM
Cadian Capital Management New York $821M AUM 14.36% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return

AlphaCentric Advisors's EVH Position: Q4 2024 in Review

AlphaCentric Advisors opened a new position in Evolent Health (EVH) in Q4 2024: 5,404 shares worth $60.8K. The stake represents 0.06% of the portfolio and ranks #186 among its holdings.

240 funds tracked by Wall St. Rank hold EVH as of Q4 2024.

  • AlphaCentric Advisors held 5,404 shares of Evolent Health worth $60.8K as of Q4 2024.
  • Evolent Health was a new AlphaCentric Advisors position in Q4 2024.
  • Evolent Health made up 0.06% of AlphaCentric Advisors's portfolio in Q4 2024, its #186 holding.
  • 240 funds tracked by Wall St. Rank held Evolent Health as of Q4 2024.

Based on AlphaCentric Advisors's 13F filing for Q4 2024, filed 31 Jan 2025.